Published by Josh White on 7th March 2019
(Sharecast News) - Liquid biopsy company Angle announced on Thursday that enrolment for its 'Parsortix' FDA clinical study for metastatic breast cancer was now complete.
URL: http://www.digitallook.com/dl/news/story/28728790/...